UNH's Q2 earnings revealed further weakness with margins at both insurance and Optum plunging to multi-year lows while sales ...

In a report released today, Ann Hynes from Mizuho Securities maintained a Buy rating on Humana, with a price target of $300.00. The company’s shares opened today at $257.53. Ele ...

Humacyte, Inc. (HUMA) closed the most recent trading day at $2.21, moving -4.33% from the previous trading session. This change lagged the S&P 500's daily gain of 0.73%. At the same time, the Dow ...

In contrast, industry giant UnitedHealth Group grew more aggressively in Medicare this year—but that growth came with soaring costs and disappointing results. Its stock has lost nearly half its value, ...